Stock Market, Economics, Equity Analysis
Monthly Archives: February 2012
Feb29
I feel like I am typing this daily but once again we have a wide divergence between the senior indexes of larger caps and the Russell 2000. This is going to resolve eventually by the large cap indexes finally relenting…
Feb29
It appears that minor setback in the market was due to Bernanke not hinting as strongly as he has in the past for QE3…. precious metals took it on the chin hard as every algo on Earth now appears to…
Feb29
It's been a remarkable rally for Apple (AAPL), and as over 10% of the NASDAQ, we can't see any form of real selling in that index until Apple weakens. That nasty reversal mid month on huge volume, is now an…
Feb28
Valeant Pharmaceuticals (VRX) is an interesting roll up company in the pharma space; the entity was formed by a mega merger of of Valeant and Biovail in late 2010 to form this $16B player. The stock has been quite weak of…
Feb28
All the strength remains in large caps, while the broader market is weak yet again. This has been the pattern for the better part of 2+ weeks now. Russell 2000 is down 0.7% as the S&P 500 is flat (and…
Sidebar
Subscribe
Explore the Fund Mark Manages
